With some viruses, once you have been infected and have developed antibodies, you will be immune to that virus for life. Past infection with the SARS-CoV-2 virus, which causes COVID-19, does not, as far as is known at this ...
Dec 16, 2020
0
3
To develop vaccines and investigate human immune responses, scientists rely on a variety of animal models, including mice that can produce human antibodies through genetically engineered B cell receptors, which are specialized ...
Dec 14, 2020
0
2
New research by scientists at the University of Chicago suggests a person's antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals ...
Dec 11, 2020
2
161
Positron emission tomography (PET) imaging with 68Ga-pentixafor is an effective diagnostic tool for central nervous system (CNS) B-cell lymphoma, according to a proof-of-concept study published in the December issue of The ...
Dec 10, 2020
0
2
Mutations in proteins called histone H1, which help package DNA in chromosomes, are a frequent cause of lymphomas, according to a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and The Rockefeller ...
Dec 10, 2020
0
84
A new biomarker discovered by a team that includes researchers from Penn Medicine identifies patients with an aggressive form of lymphoma unlikely to respond to the targeted treatment ibrutinib. It's a clinically actionable ...
Dec 7, 2020
0
2
The U.K. has become the first country to approve the Pfizer/BioNTech vaccine for widespread use. The government has ordered 40 million doses and the first batch of 800,000 doses is expected to be shipped from Belgium – ...
Dec 2, 2020
0
12
Early in the pandemic, many researchers feared people who contracted COVID could be reinfected very quickly. This was because several early studies showed antibodies seemed to wane after the first few months post-infection.
Nov 26, 2020
0
28
Unlike so many other deadly viruses, HIV still lacks a vaccine. The virus—which continues to infect millions around the world—has proven especially tricky to prevent with conventional antibodies, in part because it evolves ...
Nov 19, 2020
0
72
Immunotherapies have transformed the treatment of several types of cancer over the last decade. Yet they focus on reactivating one arm of the immune system: cytotoxic T cells, which sniff out and kill tumor cells.
Nov 19, 2020
0
59
